1. Home
  2. SIGA vs DBL Comparison

SIGA vs DBL Comparison

Compare SIGA & DBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

N/A

Current Price

$2.66

Market Cap

223.8M

Sector

Health Care

ML Signal

N/A

Logo DoubleLine Opportunistic Credit Fund of Beneficial Interest

DBL

DoubleLine Opportunistic Credit Fund of Beneficial Interest

N/A

Current Price

$13.11

Market Cap

268.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SIGA
DBL
Founded
1995
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.8M
268.5M
IPO Year
2016
2011

Fundamental Metrics

Financial Performance
Metric
SIGA
DBL
Price
$2.66
$13.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 499.5K
117.1K
Earning Date
11-09-2026
01-01-0001
Dividend Yield
★ 21.43%
8.67%
EPS Growth
N/A
★ N/A
EPS
★ 0.09
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$194.92
N/A
P/E Ratio
$30.89
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.66
$12.94
52 Week High
$7.11
$15.56

Technical Indicators

Market Signals
Indicator
SIGA
DBL
Relative Strength Index (RSI) 33.92 32.71
Support Level N/A $12.94
Resistance Level $3.43 $13.76
Average True Range (ATR) 0.22 0.15
MACD -0.05 -0.05
Stochastic Oscillator 7.25 7.15

Price Performance

Historical Comparison
SIGA
DBL

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest

Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.

Share on Social Networks: